EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

EARLY PALLIATIVE CARE FOR PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER

Raeed Khaled H.
Hamoush*

ABSTRACT

Backgr
ound: Patients with metastatic non small cell lung cancer (NSCLC) often experience significant physical
and psychological distress, yet palliative care is frequently introduced late in the disease trajectory. This study
evaluated the impact of early pallia tive care integrated with standard oncologic treatment on quality of life, mood,
healthcare utilization, and end of life care for these patients. Methods: A prospective, randomized controlled trial
was conducted with 325 newly diagnosed metastatic NSCLC pa tients. Participants were assigned to either early
palliative care plus standard oncologic care (n=163) or standard care alone (n=162). Palliative care included
monthly visits focusing on symptom management, psychosocial support, and advance care planning. Outcomes
were assessed at 12 weeks using validated tools, including the FACT L for quality of life and the PHQ 9 for
depressive symptoms. Healthcare utilization and end of life care metrics were analyzed post mortem. Results: At
12 weeks, the early pallia tive care group reported significantly improved quality of life (81.0% vs. 58.0%, p<0.001)
and lower rates of moderate to severe depression (16.0% vs. 30.2%, p=0.003). In the final 30 days of life, these
patients had fewer emergency department visits (23.9 % vs. 43.8%), hospitalizations (20.2% vs. 41.4%), and ICU
admissions (6.7% vs. 21.0%) (all p<0.001). Hospice enrollment was higher (84.0% vs. 58.0%) and occurred earlier
(74.8% vs. 38.9% enrolled >3 days before death, p<0.001). Survival was also longer in the intervention group (11.6
vs. 8.9 months). Conclusion: Early integration of palliative care for metastatic NSCLC patients significantly
enhances quality of life, reduces depressive symptoms, decreases aggressive end of life interventions, and
improves h ospice utilization. These findings support routine early palliative care as a standard component of
advanced cancer management.

Keywords: .


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2025 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: MAY ISSUE PUBLISHED

    MAY 2025 issue has been successfully launched on MAY 2025.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here